Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.
Oxford Silk Phage Technologies Logo

OSPT is pioneering a unique antibacterial biomaterial technology combining silk and bacteriophages, offering solutions for the growing surgical implant/wound infections problem.

Founded in January 2020 in Oxford, England, OSPT combines the long-term expertise of clinicians, entrepreneurs and scientists with a common passion to develop superior, natural antibacterial biomaterials which will help people live more active and longer lives. OSPT's technology offers a first of a kind, entirely natural and sustainable biomaterial made from bacteriophages and silk fibroin, minimizing the risks of infection and reducing antibiotic use.


Stephanie Lesage - Co-Founder/Director/Chief Executive Officer
Entrepreneur with 10+ years of experience in silk and vascular biomaterials


Mr James Gilbert - Co-Founder/Chief Medical Officer
Vascular Access Lead, Oxford Un. Hospitals, UK and President, VASBI



We are truly excited that OSPT has joined the Bioescalator's thriving environment in July: the access to the state-of-the-art biological facilities at the heart of Oxford's innovative and dynamic community will enable OSPT to propel the development of its first-of-a-kind medical device technology and enable its continuous growth in the next few years.

Stephanie Lesage - Co-founder, CEO, Oxford Silk Phage Technologies Ltd


Click here to visit OSPT's website